Abstract
Toxic proteins from animal venoms usually act on molecular targets that are critically involved in the function of a physiological system of a prey. With the ultimate view of designing new pharmacological tools as well as original drugs acting on these targets, animal toxins are the subject of extensive molecular analyses. In particular, the topographies by which toxins bind to their targets and hence affect the function of the associated physiological system clearly need to be identified.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Recombinant technology
Arnoux B, Ménez R, Drevet P et al (1994) Three-dimensional crystal structure of recombinant erabutoxin a at 2.0 Å resolution. FEBS Lett 342: 12–14
Bouhaouala-Zahar B, Ducancel F, Zenouaki I et al (1996) A recombinant insect-specific a-toxin of Buthus occitanus tunetanus scorpion confers protection against homologous mammal toxins. Eur. J. Biochem, 238: 653–660
Boyot P, Fillet L, Ducancel F et al (1990) A recombinant snake neurotoxin generated by chemical cleavage of a hybrid protein recovers full biological properties. FEBS Lett, 266: 87–90
Danse JM, Rowan EG, Gasparini S et al (1994) On the site by which a-dendrotoxin binds to voltage-dependent potassium channels: site-directed mutagenesis reveals that the lysine triplet 28–30 is not essential for binding. FEBS Lett, 356: 153–158
Dauplais, M, Lecoq, A, Song, J et al (1997) On the convergent evolution of animal toxins. Conservation of a diad of functional residues in potassium channel-blocking toxins with unrelated structures. J. Biol. Chem, 272: 4302–4309.
Drevet P, Lemaire C, Gasparini S et al (1997) High-level production and isotope labelling of snake neurotoxins, disulfide-rich proteins. Protein Expression and Purification, 10 (293–300)
Ducancel F, Boulain JC, Trémeau O, Ménez A (1989) Direct expression in E. coli of a functionally active protein A-snake toxin fusion protein. Protein Eng, 3: 139–143
Ducancel F, Mérienne K, Fromen-Romano C et al (1996) Mimicry between receptors and antibodies. Identification of snake toxin determinants recognized by the acetylcholine receptor and an acetylcholine receptor-mimicking monoclonal antibody. J. Biol. Chem, 271: 31345–31353
Eaker DL, Porath J (1967) The amino acid sequence of a neurotoxin from Naja nigricollis venom. Japan J. of Microbiol, 11: 353–355
Ezan E, Ducancel F, Gillet D et al (1994) Recombinant technology in the preparation of immunogen and enzymatic tracer. Application to the development of an enzyme immunoassay for rat prolactin. J. Immun Meth, 169: 205–211
Gasparini S, Kiyatkin N, Drevet P et al (1994) The low molecular weight protein which co-purifies with a-latrotoxin is structurally related to crustacean hyperglycemic hormones. J. Biol. Chem, 269: 19803–19809
Herve M, Pillet L, Humbert P et al (1992) Role and environment of the conserved Lys-27 of snake curaremimetic toxins as probed by chemical modifications, site-directed mutagenesis and photolabelling experiments, Eur. J. Biochem, 208: 125–131
Hodgson D, Gasparini S, Drevet P et al (1993) Production of recombinant notechis 11’2L, an enzymatically active mutant of a phospholipase A2 from Notechis scutatus scutatus venom, as directly generated by cleavage of a fusion protein produced in E. coli. Eur. J. Biochem, 212: 441–446
LaVallie ER, DiBlasio EA, Kovacic S et al (1993) A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Bio/Technology, 11: 187–193
Löwenadler B, Jansson B, Paleus S et al (1987) A gene fusion system for generating antibodies against short peptides. Gene, 58: 87–97
Murby M, Nguyen TN, Binz H et al (1994) Production and recovery of recombinant proteins of low solubility. Separations for Biotechnology 3 (Pyle DL, ed): Bath: B ookcr aft
Nilsson B, Abrahmsén L, Ulhén M (1985a) Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. EMBO 4: 1075–1080
Nilsson B, Holmgren E, Josephson S et al (1985b) Efficient secretion and purification of human insulin-like growth factor I with a gene fusion vector in Staphylococci. Nucleic Acids Res, 13: 1151–1162
Nilsson B, Moks T, Jansson B et al (1987) A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng, 1: 107–113
Nygren PA, Stahl S, Uhlén M (1994) Engineering proteins to facilitate bioprocessing. TIBTECH, 12: 184–188
Pillet L, Tremeau O, Ducancel F et al (1993) Genetic engineering of snake toxins: role of invariant residues in the structural and functional properties of a curaremimetic toxin, as probed by site-directed mutagenesis. J. Biol. Chem, 268: 909–916
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press
Sato A, Tamiya N (1971) The amino sequences of erabutoxins, neurotoxic proteins of sea-snake (Laticauda semifasciata venom). Biochem. J, 122: 453–461
Studier FW, Rosenberg AIL Dunn JJ, Dubendorff JW (1990) Use of T7 polymerase to direct expression of cloned genes. Methods Enzymol 185: 60–89
Tamiya N (1973) Erabutoxins a, b, and c in sea snake Laticauda semifasciata venom. Toxicon, 11: 95–97
Tamiya T, Lamouroux A, Julien J.F et al (1985) Cloning and sequence analysis of the cDNA encoding a snake neurotoxin precursor. Biochimie, 67: 185–189
Trémeau O, Lemaire C, Drevet P et al (1995) Genetic engineering of snake toxins: the functional site of erabutoxin a, as delineated by site-directed mutagenesis, includes variant residues. J. Biol. Chem, 270: 9362–9369
Vita C, Roumestand C, Toma F, Ménez A (1995) Scorpion toxins as natural scaffolds for protein engineering. Proc. Natl. Acad. Sci. USA, 92: 6404–6408
Zinn-Justin S, Pillet L, Ducancel F et al (1994) Engineering of protein epitopes: a single deletion in a snake toxin generates full binding capacity to a previously unrecognized antibody. Protein Eng, 7: 917–923
Chemical synthesis
Albericio F, Van Abel R, Barany G (1990) Solid-phase synthesis of peptides with C-terminal asparagine or glutamine. Int. J. Pept. Prot. Res, 35: 284–286
Atherton E, Sheppard RC (1989) Solid Phase Peptide Synthesis, a Practical Approach. Oxford: IRL Press at Oxford University Press
Breipohl G, Knolle J, Stüber W (1990) Facile SPS of peptides having C-terminal Asn and Gln. Int. J. Pept. Prot. Res, 35: 281–283
Byrnes ME, Mahnir VM, Kern WR, Pennington MW (1995) Synthesis and characterization of dendrotoxin: a potent potassium channel inhibitor. Protein Peptides Lett 1: 239–245
Kuroda H, Chen YN, Watanabe TX et al (1992) Solution synthesis of calsiseptine, an L-Type specific calcium channel blocker. Pept. Res, 5 (5): 265–268
Merrifield RB (1963) The synthesis of a tetrapeptide, J. Am. Chem. Soc, 85: 2149–2154
Mourier G, Zinn-Justin S, Trémeau 0, Ménez A (1996) Chemical synthesis and in vitro folding of the curaremimetic toxin α from Naja nigricollis: a three-finger fold protein. Proceedings of the 24th European Peptides Symposium, Edinburgh pp. 659–660
Nishio H, Kumagaye Y, Kubo S et al (1993) Synthesis of ω-agatoxin IV A and its related peptides. Biochem Biophys. Res. Comm, 1447–1453
Stewart JM, Young JD (1984) Solid Phase Peptide Synthesis, 2nd edn. Pierce Chemical Company
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Boulain, JC., Ducancel, F., Mourier, G., Drevet, P., Ménez, A. (2000). “Three-Fingered” Toxins from Hydrophid and Elapid Snakes: Artificial Procedures to Overproduce Wild-Type and Mutated Curaremimetic Toxins. In: Rochat, H., Martin-Eauclaire, MF. (eds) Animal Toxins. Methods and Tools in Biosciences and Medicine. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8466-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8466-2_15
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-7643-6020-7
Online ISBN: 978-3-0348-8466-2
eBook Packages: Springer Book Archive